188 related articles for article (PubMed ID: 29346433)
1. Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6.
Chen J; OuYang H; An X; Liu S
PLoS One; 2018; 13(1):e0191325. PubMed ID: 29346433
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer chromatin analysis of the human vtRNA genes uncovers their association with cancer biology.
Fort RS; Duhagon MA
F1000Res; 2021; 10():182. PubMed ID: 34354812
[No Abstract] [Full Text] [Related]
3. Binding of LINE-1 RNA to PSF transcriptionally promotes GAGE6 and regulates cell proliferation and tumor formation
Lv J; Zhao Z
Exp Ther Med; 2017 Aug; 14(2):1685-1691. PubMed ID: 28810637
[TBL] [Abstract][Full Text] [Related]
4. Expression of the vault RNA protects cells from undergoing apoptosis.
Amort M; Nachbauer B; Tuzlak S; Kieser A; Schepers A; Villunger A; Polacek N
Nat Commun; 2015 May; 6():7030. PubMed ID: 25952297
[TBL] [Abstract][Full Text] [Related]
5. The Small Non-coding Vault RNA1-1 Acts as a Riboregulator of Autophagy.
Horos R; Büscher M; Kleinendorst R; Alleaume AM; Tarafder AK; Schwarzl T; Dziuba D; Tischer C; Zielonka EM; Adak A; Castello A; Huber W; Sachse C; Hentze MW
Cell; 2019 Feb; 176(5):1054-1067.e12. PubMed ID: 30773316
[TBL] [Abstract][Full Text] [Related]
6. The human vault RNA enhances tumorigenesis and chemoresistance through the lysosome in hepatocellular carcinoma.
Ferro I; Gavini J; Gallo S; Bracher L; Landolfo M; Candinas D; Stroka DM; Polacek N
Autophagy; 2022 Jan; 18(1):191-203. PubMed ID: 33960270
[TBL] [Abstract][Full Text] [Related]
7. Loss of 5-methylcytosine alters the biogenesis of vault-derived small RNAs to coordinate epidermal differentiation.
Sajini AA; Choudhury NR; Wagner RE; Bornelöv S; Selmi T; Spanos C; Dietmann S; Rappsilber J; Michlewski G; Frye M
Nat Commun; 2019 Jun; 10(1):2550. PubMed ID: 31186410
[TBL] [Abstract][Full Text] [Related]
8. Retraction: Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6.
PLOS ONE Editors
PLoS One; 2024; 19(3):e0300808. PubMed ID: 38530794
[No Abstract] [Full Text] [Related]
9. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
[TBL] [Abstract][Full Text] [Related]
10. The vault RNA of
Kolev NG; Rajan KS; Tycowski KT; Toh JY; Shi H; Lei Y; Michaeli S; Tschudi C
J Biol Chem; 2019 Oct; 294(43):15559-15574. PubMed ID: 31439669
[TBL] [Abstract][Full Text] [Related]
11. Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP.
Emre N; Raval-Fernandes S; Kickhoefer VA; Rome LH
Biochim Biophys Acta; 2004 Apr; 1678(1):33-46. PubMed ID: 15093136
[TBL] [Abstract][Full Text] [Related]
12. Direct activation of the human major vault protein gene by DNA-damaging agents.
Shimamoto Y; Sumizawa T; Haraguchi M; Gotanda T; Jueng HC; Furukawa T; Sakata R; Akiyama S
Oncol Rep; 2006 Mar; 15(3):645-52. PubMed ID: 16465425
[TBL] [Abstract][Full Text] [Related]
13. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
Huffman KE; Corey DR
Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
[TBL] [Abstract][Full Text] [Related]
14. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
[TBL] [Abstract][Full Text] [Related]
15. Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA.
Wang G; Cui Y; Zhang G; Garen A; Song X
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16794-8. PubMed ID: 19805375
[TBL] [Abstract][Full Text] [Related]
16. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
Stein U; Bergmann S; Scheffer GL; Scheper RJ; Royer HD; Schlag PM; Walther W
Oncogene; 2005 May; 24(22):3606-18. PubMed ID: 15750632
[TBL] [Abstract][Full Text] [Related]
17. NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.
Galietta A; Gunby RH; Redaelli S; Stano P; Carniti C; Bachi A; Tucker PW; Tartari CJ; Huang CJ; Colombo E; Pulford K; Puttini M; Piazza RG; Ruchatz H; Villa A; Donella-Deana A; Marin O; Perrotti D; Gambacorti-Passerini C
Blood; 2007 Oct; 110(7):2600-9. PubMed ID: 17537995
[TBL] [Abstract][Full Text] [Related]
18. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
Zheng CL; Sumizawa T; Che XF; Tsuyama S; Furukawa T; Haraguchi M; Gao H; Gotanda T; Jueng HC; Murata F; Akiyama S
Biochem Biophys Res Commun; 2005 Jan; 326(1):100-7. PubMed ID: 15567158
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
Mossink MH; van Zon A; Fränzel-Luiten E; Schoester M; Kickhoefer VA; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2002 Dec; 62(24):7298-304. PubMed ID: 12499273
[TBL] [Abstract][Full Text] [Related]
20. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP).
Lehuédé C; Li X; Dauvillier S; Vaysse C; Franchet C; Clement E; Esteve D; Longué M; Chaltiel L; Le Gonidec S; Lazar I; Geneste A; Dumontet C; Valet P; Nieto L; Fallone F; Muller C
Breast Cancer Res; 2019 Jan; 21(1):7. PubMed ID: 30654824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
